comparemela.com
Home
Live Updates
QUANTUM GENOMICS: Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity : comparemela.com
QUANTUM GENOMICS: Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity
Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity Firibastat expected to launch in late 2023 for difficult-to-treat/resistant hypertension. Gross cash of €24.9
Related Keywords
Australia ,
Taiwan ,
United States ,
New Zealand ,
Paris ,
France General ,
France ,
Brazil ,
Canada ,
South Korea ,
Greece ,
French ,
Brazilian ,
Jean Philippe Milon ,
South East Asia ,
Catherine Llorens Cort ,
Mike Tattory ,
Biolab Pharma ,
Linkedin ,
Twitter ,
Drug Administration ,
Descartes University ,
Orient Europharma Co ,
Quantum Genomics Publishes ,
Euronext Growth ,
Philippe Milon ,
Chief Executive Officer ,
Quantum Genomics ,
Orient Europharma ,
Brain Aminopeptidase ,
Paris Descartes University ,
Euronext Growth Paris ,
Quantum ,
Genomics ,
Ublishes ,
021 ,
Calf ,
Ear ,
Results ,
Reviews ,
Linical ,
Activity ,
comparemela.com © 2020. All Rights Reserved.